I suppose fellas that the half yearly report places the worth of...

I suppose fellas that the half yearly report places the worth of each NRT share at 1.57 cents.

Value is something else. That's why I'm holding and buying where I can.

Should Novogen acquire some serious investment interest from Sachs and/or Cavendish then lets see what happens then because the shares should be worth a lot more.

And that will help to drive the percieved value.

A successful trial in in female population is probably going to be what the market really wants. And we remain on course for that.